The European Directorate for the Quality of Medicines & Healthcare (EDQM) has issued a CEP certificate for our Vincamine product, making Linnea the first company in the world to have a CEP-certified Vincamine extract.
CEP is a Certificate of Suitability to the monographs of the European Pharmacopoeia that centralizes the evaluation of the quality of pharmaceutical substances, and consequently certifies the compliance of the Active Pharmaceutical Ingredient (API) with the rules and specifications stated in the European Pharmacopoeia. Moreover, the CEP certification offers the advantage to speed up and simplify the regulatory lifecycle management in the countries where it is recognized.
To see the list of countries where the CEP certification is recognized, visit the EDQM website.
To learn more about Linnea’s portfolio, contact us at
e-mail: [email protected]
phone +41 91 850 50 55